Cargando…
Role of Melatonin in the Management of Sleep and Circadian Disorders in the Context of Psychiatric Illness
PURPOSE OF REVIEW: We present a review of research on the role of melatonin in the management of sleep and circadian disorders, stressing current overall view of the knowledge across psychiatric disorders. RECENT FINDINGS: Dysregulation of sleep and circadian rhythms has been established in several...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633504/ https://www.ncbi.nlm.nih.gov/pubmed/36227449 http://dx.doi.org/10.1007/s11920-022-01369-6 |
_version_ | 1784824254001315840 |
---|---|
author | Moon, Eunsoo Kim, Kyungwon Partonen, Timo Linnaranta, Outi |
author_facet | Moon, Eunsoo Kim, Kyungwon Partonen, Timo Linnaranta, Outi |
author_sort | Moon, Eunsoo |
collection | PubMed |
description | PURPOSE OF REVIEW: We present a review of research on the role of melatonin in the management of sleep and circadian disorders, stressing current overall view of the knowledge across psychiatric disorders. RECENT FINDINGS: Dysregulation of sleep and circadian rhythms has been established in several psychiatric and neurocognitive disorders for long. Recent research confirms this finding consistently across disorders. The secretion of melatonin in schizophrenia and neurocognitive disorders is reduced due to a smaller volume and enlarged calcification of the pineal gland. On the other hand, melatonin dysregulation in bipolar disorder may be more dynamic and caused by light-sensitive melatonin suppression and delayed melatonin secretion. In both cases, exogenous melatonin seems indicated to correct the dysfunction. However, a very limited number of well-designed trials with melatonin to correct sleep and circadian rhythms exist in psychiatric disorders, and the evidence for efficacy is robust only in autism, attention deficit hyperactivity disorder (ADHD), and neurocognitive disorders. This topic has mainly not been of interest for recent work and well-designed trials with objective circadian parameters are few. Overall, recent studies in psychiatric disorders reported that melatonin can be effective in improving sleep parameters such as sleep onset latency, sleep efficiency, and sleep quality. Recent meta-analysis suggests that optimal dosage and dosing time might be important to maximize the efficacy of melatonin. The knowledge base is sufficient to propose well-designed, larger trials with circadian parameters as inclusion and outcome criteria. Based on the partly fragmentary information, we propose testing efficacy in disorders with neurocognitive etiopathology with later and higher dosing, and affective and anxiety disorders with lower and earlier dosing of melatonin. SUMMARY: Melatonin is promising for the correction of sleep and circadian abnormalities in psychiatric disorders. However, research results on its effect are still few and need to be accumulated. For effective use of melatonin, it is necessary to consider the appropriate dosage and administration time, depending on the individual abnormality of sleep and circadian rhythms. |
format | Online Article Text |
id | pubmed-9633504 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-96335042022-11-05 Role of Melatonin in the Management of Sleep and Circadian Disorders in the Context of Psychiatric Illness Moon, Eunsoo Kim, Kyungwon Partonen, Timo Linnaranta, Outi Curr Psychiatry Rep Sleep Disorders (P Gehrman, Section Editor) PURPOSE OF REVIEW: We present a review of research on the role of melatonin in the management of sleep and circadian disorders, stressing current overall view of the knowledge across psychiatric disorders. RECENT FINDINGS: Dysregulation of sleep and circadian rhythms has been established in several psychiatric and neurocognitive disorders for long. Recent research confirms this finding consistently across disorders. The secretion of melatonin in schizophrenia and neurocognitive disorders is reduced due to a smaller volume and enlarged calcification of the pineal gland. On the other hand, melatonin dysregulation in bipolar disorder may be more dynamic and caused by light-sensitive melatonin suppression and delayed melatonin secretion. In both cases, exogenous melatonin seems indicated to correct the dysfunction. However, a very limited number of well-designed trials with melatonin to correct sleep and circadian rhythms exist in psychiatric disorders, and the evidence for efficacy is robust only in autism, attention deficit hyperactivity disorder (ADHD), and neurocognitive disorders. This topic has mainly not been of interest for recent work and well-designed trials with objective circadian parameters are few. Overall, recent studies in psychiatric disorders reported that melatonin can be effective in improving sleep parameters such as sleep onset latency, sleep efficiency, and sleep quality. Recent meta-analysis suggests that optimal dosage and dosing time might be important to maximize the efficacy of melatonin. The knowledge base is sufficient to propose well-designed, larger trials with circadian parameters as inclusion and outcome criteria. Based on the partly fragmentary information, we propose testing efficacy in disorders with neurocognitive etiopathology with later and higher dosing, and affective and anxiety disorders with lower and earlier dosing of melatonin. SUMMARY: Melatonin is promising for the correction of sleep and circadian abnormalities in psychiatric disorders. However, research results on its effect are still few and need to be accumulated. For effective use of melatonin, it is necessary to consider the appropriate dosage and administration time, depending on the individual abnormality of sleep and circadian rhythms. Springer US 2022-10-13 2022 /pmc/articles/PMC9633504/ /pubmed/36227449 http://dx.doi.org/10.1007/s11920-022-01369-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Sleep Disorders (P Gehrman, Section Editor) Moon, Eunsoo Kim, Kyungwon Partonen, Timo Linnaranta, Outi Role of Melatonin in the Management of Sleep and Circadian Disorders in the Context of Psychiatric Illness |
title | Role of Melatonin in the Management of Sleep and Circadian Disorders in the Context of Psychiatric Illness |
title_full | Role of Melatonin in the Management of Sleep and Circadian Disorders in the Context of Psychiatric Illness |
title_fullStr | Role of Melatonin in the Management of Sleep and Circadian Disorders in the Context of Psychiatric Illness |
title_full_unstemmed | Role of Melatonin in the Management of Sleep and Circadian Disorders in the Context of Psychiatric Illness |
title_short | Role of Melatonin in the Management of Sleep and Circadian Disorders in the Context of Psychiatric Illness |
title_sort | role of melatonin in the management of sleep and circadian disorders in the context of psychiatric illness |
topic | Sleep Disorders (P Gehrman, Section Editor) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633504/ https://www.ncbi.nlm.nih.gov/pubmed/36227449 http://dx.doi.org/10.1007/s11920-022-01369-6 |
work_keys_str_mv | AT mooneunsoo roleofmelatonininthemanagementofsleepandcircadiandisordersinthecontextofpsychiatricillness AT kimkyungwon roleofmelatonininthemanagementofsleepandcircadiandisordersinthecontextofpsychiatricillness AT partonentimo roleofmelatonininthemanagementofsleepandcircadiandisordersinthecontextofpsychiatricillness AT linnarantaouti roleofmelatonininthemanagementofsleepandcircadiandisordersinthecontextofpsychiatricillness |